OverviewChartNewsTraderScreen

UBS Call 100 BNTX 18.10.2024/  DE000UM4D9B9  /

Frankfurt Zert./UBS
9/26/2024  10:02:20 AM Chg.0.000 Bid9:54:47 PM Ask9:54:47 PM Underlying Strike price Expiration date Option type
0.920EUR 0.00% -
Bid Size: -		 -
Ask Size: -		 BioNTech SE 100.00 USD 10/18/2024 Call
GlobeNewswire 8/29 Advanced Medical Balloons appoints top-performing US life-science executive to drive business growth
TeleTrader 8/22 FDA okays Moderna, Pfizer updated vaccines
GlobeNewswire 8/22 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire 8/16 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
GlobeNewswire 8/14 Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 8/8 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 8/8 Genmab Updates 2024 Financial Guidance
TeleTrader 8/5 BioNTech posts revenue at €128.7 billion in Q2
GlobeNewswire 8/5 BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 8/5 Genmab Takes Full Control of Acasunlimab Development Program
GlobeNewswire 8/1 Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 7/30 BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patie...
GlobeNewswire 7/22 BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
GlobeNewswire 6/27 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 6/24 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire 6/1 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 5/29 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 5/21 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 5/21 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 5/17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 5/17 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire 5/9 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
TeleTrader 5/6 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 5/6 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
TeleTrader 5/6 Europe mixed premarket with data on the limelight